When does Mounjaro’s patent end?
Mounjaro (tirzepatide) is protected by multiple patents covering different aspects of the product (the drug substance, specific formulations, and methods of use). That means there is not a single “end date” for all protection—patent expiry can vary by patent and by country.
What date applies in the U.S.?
For the U.S., the practical “patent end” most people are looking for is the expiry date of the key composition-of-matter and related patents for tirzepatide, which are spread across several patent numbers and listed grant/expiration terms. Patent expiration timing can also be affected by patent term adjustments and extensions tied to regulatory approvals.
For a consolidated view of relevant U.S. patent expiries tied to Mounjaro, see DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search “Mounjaro” or “tirzepatide” on the site).
Are there other protections besides patents that can keep it off the market?
Even after patent expiry, Mounjaro may still face additional exclusivities and regulatory protections (depending on the specific filing and jurisdiction). In the U.S., biologic-style exclusivity frameworks don’t apply the same way to every diabetes drug, but there can still be regulatory exclusivity periods and other IP (like method-of-use patents) that matter for generic or biosimilar-style entry.
Do “patent end” and “generic availability” happen at the same time?
Not always. Even if one patent expires, other patents may still block competitors. Generic development and any approved label changes also depend on which patents a challenger targets (and whether the FDA approval pathway allows a change in indications that avoids infringement).
What if you want the exact date for your situation?
To give the exact “end date,” you need the jurisdiction (U.S., EU, UK, etc.) and which type of entry you mean (generic/ANDA vs. other pathways). If you tell me the country and whether you mean tirzepatide generally or Mounjaro’s specific protected use(s), I can point you to the most relevant patent expiry dates from DrugPatentWatch.com for that scenario.